Corcept Therapeutics (CORT) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $92.29 +2.31%
EPS Growth %: -96.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -96.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $105.7 million versus the consensus estimate of $104.91 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- Volato Group reports Q2 2026 preliminary results with Vaunt growth
- HSBC sees more upside in Intel stock on server CPU opportunity
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
